What is NEWTH's health score?

NewtekOne, Inc. (NEWTH) has a TradeApes health score of 43 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is NEWTH's estimated fair value?

Based on our 5-year discounted cash flow model, NewtekOne, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is NEWTH undervalued or overvalued?

Our model currently rates NEWTH as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for NEWTH... Refresh in a moment for the full analysis.

NewtekOne, Inc. (NEWTH)

Financials Fair Value Low weak

Updated: 2026-04-21

TradeApes Score

reduce

Financial Strength

45 Mixed

Operating Trend

40 Weak

Relative Value

50 Mixed

Capital Allocation

20 Stressed

Risk

65 Healthy

Key Findings

+ Low P/E — below 12×, potential value relative to earnings

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.